Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1989 Feb;44(2):136-40.
doi: 10.1136/thx.44.2.136.

Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline

Affiliations
Clinical Trial

Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline

J Crane et al. Thorax. 1989 Feb.

Abstract

The cardiovascular and hypokalaemic effects of equal doses of inhaled fenoterol, isoprenaline and salbutamol were compared in eight healthy male volunteers, in a double blind, placebo controlled study. Increasing doses of 400, 600, and 800 micrograms were given from a metered dose inhaler at 15 minute intervals, followed by measurements of heart rate, blood pressure, total electromechanical systole (as a measure of inotropic response), QTc interval, and plasma potassium concentration. After repeated inhalation, fenoterol resulted in significantly greater chronotropic, electrocardiographic, and hypokalaemic effects than either isoprenaline or salbutamol. The maximum inotropic effect of fenoterol was similar to that of isoprenaline.

PubMed Disclaimer

Comment in

References

    1. Br Med J (Clin Res Ed). 1984 Aug 11;289(6441):348-51 - PubMed
    1. Clin Pharmacol Ther. 1984 Jun;35(6):762-7 - PubMed
    1. Clin Pharmacol Ther. 1986 Jul;40(1):108-15 - PubMed
    1. Eur J Respir Dis Suppl. 1986;147:175-81 - PubMed
    1. Lancet. 1987 Oct 10;2(8563):863-4 - PubMed

Publication types